Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Size-dependent effects of graphene oxide on the osteogenesis of human adipose-derived mesenchymal stem cells.

Kang ES., Song I., Kim DS., Lee U., Kim JK., Son H.

Laboratory Study on Face & Skin, published in Colloids Surf B Biointerfaces (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Colloids Surf B Biointerfaces (2018)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
29747027
DOI
10.1016/j.colsurfb.2018.04.053
Citations
29

Abstract (original English)

Graphene derivatives are known to be suitable for biomedical applications, especially for stem cell-based therapies. Herein, we report the size effects of graphene oxide (GO) on differentiation of human adipose-derived mesenchymal stem cells (hADMSCs), using micro-sized (MGO) and nano-sized graphene oxide (NGO) sheets. The MGO and NGO sheets having lateral sizes of 1-10 μm and 100-300 nm, respectively, are coated on glass substrates by drop casting. The hADMSCs grown on the MGO-coated substrates show enhanced cell spreading and proliferation rate when compared with those of NGO counterpart, regardless of their densities. The GO size-dependency of hADMSCs becomes more prominent when it comes to their differentiation capabilities. After 4 weeks of differentiation under the same culture conditions, the osteogenesis of hADMSCs grown on the MGO-coated substrate is particularly higher than that on the NGO-coated substrate. The difference in osteogenic differentiation of hADMSCs is found to be most dominant after 21-28 days of differentiation according to the calcification level of osteoblasts. These finding signify the importance of graphene size in controlling the osteogenesis of hADMSCs, which may shed new insight into the use of graphene-based materials for stem cell research and therapy.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueCell DifferentiationCell ProliferationCells, CulturedGraphiteHumansMesenchymal Stem CellsOsteogenesisParticle SizeSurface Properties

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research